This is a type of cancer that starts in the cells that line glands. It's a serious condition where abnormal cells grow uncontrollably.
Every report comes from a Lived member, sent anonymously.
Have you had Hysterectomy for Adenosarcoma?
Adenosarcoma, also called Mullerian adenosarcoma, is a rare cancer of the female reproductive tract. It most often starts in the lining of the uterus, and less often in the cervix, the ovary or tissue outside the uterus. The tumor has two parts: glands that look benign under the microscope, surrounded by connective tissue that is cancerous. That cancerous connective tissue is a sarcoma, which is why adenosarcoma is grouped with the uterine sarcomas rather than with the more common endometrial cancers. It usually grows as a polyp-like mass inside the uterus, sometimes large enough to push down into the cervix. The most common symptoms are abnormal vaginal bleeding and pelvic pain or pressure. Most uterine adenosarcomas are found while still limited to the uterus, and many people do well after treatment, but the cancer can come back, so it needs careful follow-up.
The cause of adenosarcoma is not known, and most people who develop it have no identifiable risk factor. It is most common around and after menopause, but it can occur in younger women and, rarely, in teenagers. For uterine sarcomas as a group, prior radiation therapy to the pelvis and taking tamoxifen (a hormone-blocking medicine used to treat or prevent breast cancer) are linked to higher risk. Adenosarcomas that arise outside the uterus, such as in the ovary, often develop in areas of endometriosis, where tissue similar to the uterine lining grows elsewhere in the pelvis. These are associations, not certainties: most people with these exposures never develop adenosarcoma.
Evaluation of abnormal bleeding or a pelvic mass usually starts with a pelvic exam and imaging such as ultrasound or MRI (magnetic resonance imaging). A sample of tissue is then needed, either a biopsy of the uterine lining, a D&C (dilation and curettage, a minor procedure that removes tissue from inside the uterus) or removal of the polyp itself. A pathologist makes the diagnosis by seeing the characteristic mix of benign glands and cancerous connective tissue under the microscope. Because adenosarcoma can look like an ordinary benign polyp, it is sometimes missed at first, especially when a polyp keeps coming back after removal. A polyp that returns, grows quickly or bleeds heavily is a reason to have the tissue examined. The full diagnosis often comes after hysterectomy, when the pathologist can measure two things that strongly affect outlook: how deeply the tumor has grown into the muscle wall of the uterus, and whether there is sarcomatous overgrowth, meaning the cancerous part makes up more than a quarter of the tumor. Together with whether the cancer has spread beyond the uterus, these findings set the stage and guide what comes next.
Surgery is the main treatment. For adenosarcoma of the uterus or cervix, this is usually a hysterectomy (removal of the uterus and cervix), often with removal of both fallopian tubes and ovaries. Because these tumors rarely spread to lymph nodes, removing lymph nodes is not routinely recommended. For younger people with early-stage disease and no high-risk features, keeping the ovaries, and in carefully selected cases the uterus, may be possible, though the evidence comes from small numbers of patients and the trade-off needs a frank discussion with a gynecologic oncologist. Whether extra treatment after surgery helps is uncertain. Chemotherapy or radiation may be offered when the tumor has high-risk features such as sarcomatous overgrowth or deep invasion, but studies have not shown a clear survival benefit. Many adenosarcomas carry receptors for estrogen or progesterone, and hormone-based treatment that lowers or blocks these hormones' effects is sometimes used, based on encouraging but limited reports. Adenosarcomas outside the uterus, and cancer that comes back, are usually treated with surgery to remove as much tumor as possible, sometimes followed by chemotherapy. Because the disease is rare, treatment at a center experienced with uterine sarcomas, and asking about clinical trials, can be worthwhile.
Recovery from hysterectomy usually takes four to six weeks, longer after open abdominal surgery. Periods stop and pregnancy is no longer possible. If both ovaries are removed before menopause, menopause symptoms usually begin soon after surgery, and how to manage them is worth discussing with the care team, especially when the tumor responds to hormones. The outlook for most people with uterine adenosarcoma limited to the uterus is favorable, but recurrence is a real possibility. In published series, somewhere between a quarter and nearly half of people have the cancer come back, most often in the pelvis, and it can return years after treatment. Sarcomatous overgrowth is the feature most strongly linked to recurrence; without it, the risk is considerably lower. Ovarian adenosarcoma tends to behave more aggressively than the uterine form. Follow-up usually involves regular visits with pelvic exams and imaging as advised, more often in the first few years and continuing for the long term. Living with that uncertainty can be hard, and support from the care team, counselors or other people with rare gynecologic cancers can help.
Arrange an evaluation for any vaginal bleeding after menopause, bleeding between periods or after sex, a polyp that keeps returning after removal, or ongoing pelvic pain or pressure. If you take tamoxifen, report any abnormal bleeding to your clinician so it can be checked. After treatment, contact your care team about new vaginal bleeding, new or worsening pelvic or abdominal pain or swelling, or other symptoms that persist, rather than waiting for the next scheduled visit.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Adenosarcoma is like, what's helped you, or ask the community a question.